, and one new tyrosine-derived alkaloid named as gymnastatin Z (8), together with two known compounds, phomacin B (7) and triticone D (9), were isolated from a solid-substrate fermentation culture of Westerdykella dispersa which was derived from marine sediments. Their structures were established on the basis of spectroscopic analysis using 1D and 2D NMR techniques, and comparison of NMR data to those of known compounds. The anti-bacterial and cytotoxic activities assays of all isolated compounds were evaluated against eight human pathogenic bacteria and five human cancer cell lines, respectively. Compound 8 exhibited moderate activity against B. subtilis with MIC values of 12.5 µg/mL, while compounds 5, 7 and 8 displayed moderate inhibitory activities against five human cancer cell lines (MCF-7, HepG2, A549, HT-29 and SGC-7901), with IC 50 values ranging from 25.6 to 83.7 µM.
, and since then, over 200 related derivatives have been reported from various fungi including ascomycetes as well as basidiomycetes, as exemplified by the genera Aspergillus, Penicillium, Chaetomium, Zygosporium, Phoma, Rosellinia, Ascochyta, Metarhizum, Xylaria, Phomopsis or Hypoxylon [4] [5] [6] [7] [8] . Various cytochalasans exert a wide range of biological activities, such as interfering with cytokinesis, intracellular motility [9] [10] [11] [12] , monosaccharide transport systems 13, 14 , or intracellular Ca 2+ regulation 15 , inhibiting thyroid secretion 16 , or displaying cytotoxic 17, 18 , antimicrobial or antiparasitic properties [19] [20] [21] [22] [23] . As part of our program to discover structurally unique and biologically active secondary metabolites from fungi of unique ecological niches, the chemical investigation on Westerdykella dispersa was carried out, resulting 8), together with two known compounds, phomacin B (7) and triticones D (9) (Fig. 1) . Herein, we report the fermentation, isolation, structure elucidation, and biological activities of these isolated compounds.
Results and Discussion
Structure Elucidation. Compound 1 was isolated as a colorless block crystal with a molecular formula C 25 H 37 NO 4 , as suggested by the HRESIMS data at m/z 438.26152 [M + Na] + (calcd for 438.26148). Interpretation of its 1 H, 13 C NMR, DEPT, and HMQC spectra revealed 25 carbon resonances ascribed to five methyls, six sp 3 methylenes (one of which oxygenated), six sp 3 methines, two sp 2 methines, one sp 3 nonprotonated carbon, two sp 2 nonprotonated carbons, and three carboxyl groups. The molecular formula requires eight degrees of unsaturation, but only three carboxyl and four olefinic carbons resonating at δ C 175.8 (s, C-1), 207.8 (s, C-18), 208.1 (s, C-21), 139.7 (s, C-6), 125.6 (d, C-7), 124.8 (d, C-13), and 136.7 (s, C-14) were detected, indicating the tricyclic nature of 1. Four spin systems could be detected in the COSY spectrum as depicted in Fig. 2 . Detailed analyses of the 1D and 2D NMR spectroscopic data revealed that 1 had a similar structure to phomacin C, a cytochalasan-based alkaloid characterized from Phoma sp 2 . The main differences between the two compounds are at positions C-18, C-19 and C-20, with the hydroxyl group (C-18) and the C-19/C-20 trans-olefin in phomacin C being replaced by the two sp 3 methylenes at positions C-19 and C-20, and ketone substituent at C-18 in 1. This suggested that the C-19/C-20 trans-olefin in phomacin C was reduced, and then oxidative reaction occurred at C-18 to form 1. The observed HMBC and COSY correlations (Fig. 2) supported the above deduction. On the basis of the above data, the gross structure of 1 was established. The relative configurations of 1 were determined to be 3 S*, 4 R*, 5 S*, 8 S*, 9 S*, and 16 S*, by comparing the NMR data with those reported for phomacin C as well as by the NOESY spectroscopic data (Fig. 3 ), which were in agreement with those of phomacin C. This was confirmed by the X-ray single-crystal diffraction (Fig. 4) Tables 1 and 2 ) closely resembled those of 1, except for the presence of one additional oxygenated methyl and one oxygnated methine, and the absence of one sp 3 methylene in 2. This suggested that the methoxylation occurred at C-19 position in 1 to form 2, evident from HMBC correlations of H-19 with C-21, and H-27 with C-19, combined with correlation of H-19 with H-20 in the COSY spectrum (Fig. 2) . The relative configurations of all stereocenters except for C-19 in 2 was characterized the same as in 1 by analysis of NOESY correlations and by comparison of its NMR data with those of 1. While the absolute configuration of C-19 was determined to be S by computational method via calculation of the electronic circular dichroism (ECD) (Fig. 5A) , which was also supported by the (Fig. 3) . Therefore, the structure of 2 was characterized as 18-oxo-19-methoxy-19,20-dihydrophomacin C.
Compound 3 had the molecular formula C 25 H 37 NO 5 , as evidenced by the HRESIMS molecular ion at m/z 454.25676 ([M + Na] + , calcd for 454.25639), requiring eight degrees of unsaturation, which is 14 mass units less than that of 2. The NMR data ( Tables 1 and 2 ) of 3 revealed nearly identical structural features to those of 2, except that the methoxy group at C-19 was replaced by a hydroxyl substituent, which was further supported by HMBC and COSY correlations (Fig. 2) . This suggested that compound 3 is the non-methylated derivative of 2. Detailed analyses of its NMR and NOESY data revealed the relative configurations of all stereocenters except for C-19 in 3 are the same as in 2. Unfortunately, it is difficult to determine the stereochemistry of C-19 through NOESY experiments. Thus, the absolute configuration of C-19 was determined to be R through calculation of the electronic circular dichroism (ECD) (Fig. 5B) 13 C NMR data were extremely similar to those of 1, except for the absence of a carboxyl group (δ C 207.8 (s, C-18)) and the appearance of an additional oxygenated methine (δ H 3.76 (m, H-18); δ C 68.8 (d, C-18)) in 4. This suggested that compound 4 is a reductive derivative of 1, which was confirmed by the HMBC and COSY experiments (Fig. 2) . The relative stereochemistry of all chiral centers except for C-18 were the same as in 1-3 and phomacin C based upon coupling constants and chemical shift comparisons, which was further confirmed by the detected NOESY correlations (Fig. 3) . While the absolute configuration of C-18 was determined to be R through calculation of the electronic circular dichroism (ECD) (Fig. 5C) Spectra were recorded at 600 MHz.
suggested that the methoxylation occurred at C-19 in 4 to form 5, which was further supported by the HMBC correlations of H-19 with C-21, H-27 with C-19, along with the correlations of H-18 with H-19 observed in the COSY spectrum (Fig. 2) . The relative stereochemistry of all chiral centers except for C-18 and C-19 were in accord with those of compounds 1-4 based upon coupling constants and chemical shift comparisons, which was further confirmed by the NOESY correlations as depicted in Fig. 3 . Furthermore, the α-orientations of hydroxyl group at position C-18 and methoxy group at position C-19 were determined by ROESY correlations of H-13 with H-8, H-16, H-17a and H-20a, H-20a with H-18, and H-19 with H-17a, which allowed us to determine the relative configuration of C-18 and C-19 as S* and S*, respectively. Therefore, compound 5 was determined to be 19-methoxy-19,20-dihydrophomacin C. The molecular formula of 6, which was obtained as an amorphous white powder, was determined to be C 25 H 39 NO 5 as deduced by HRESIMS at m/z 456.27169 [M + Na] + (calcd for 456.27204), requiring 7 degrees of unsaturation. The molecular weight of 6 was found to be 14 mass units less than that of 5. Its 1 H and 13 C NMR spectra (Tables 1 and 2) showed resonances for five methyls, five methylenes, ten methines, and five quaternary carbons. Comparison of its NMR spectra with compound 5 revealed resonances nearly identical to those found in the spectra of 5, except that the resonance for OMe-19 were not observed, suggesting that 6 was the non-methylated analogues of 5. Further analysis of the COSY and HMBC spectra confirmed the structure of 6 as shown in Fig. 1 . The relative configurations of 6 are in agreement with those of 5, by comparison of the 1 H and 13 C NMR spectroscopic data with those of 1, as well as the observed NOESY correlations (Fig. 3) . Therefore, compound 6 is identified as 19-hydroxyl-19,20-dihydrophomacin C. . The COSY spectrum as depicted in Fig. 3 revealed an extended spin system comprising H-12 through H-3 to H-26 HMBC, along with the observed HMBC correlations from H-25 to C-13 and C-15, disclosed the presence of a branched aliphatic chain from C-11 to C-24. Detailed analysis of the 1 H and 13 C NMR data of 8 revealed the presence of structural features similar to those found in the known compound, gymnastatin H reported from the sponge-derived fungus Gymnascella dankaliensis, suggesting compound 8 to be a new gymnastatin derivative 25 . The distinct differences between 8 and gymnastatin H are that the length of the branched aliphatic chain was increased by two methylenes, and the replacing of the carboxylic acid methyl ester group in gymnastatin H by a hydroxymethyl group in 8, as evident from the COSY correlation of H-1 with H-2, and the Table 2 . 13C NMR (100 MHz) data for compounds 1-6 in CDCl 3 (δ in ppm).
Pos
HMBC correlation of H-1 with C-3 (Fig. 2) . The E-forms of all olefinic double bonds of the side chain as same in gymnastatin were deduced on the basis of their respective coupling constants. Unfortunately, the stereochemistry of C-2 and C- 16 could not yet be clarified due to scarcity of material. Thus, compound 8 was identified and designated as gymnastatin Z considering that this compound belonged to gymnastatin derivatives and the gymnastatins A-Y have been already reported 26, 27 . Two known compounds 7 and 9 were characterized as phomacin B 24 , and triticone D In conclusion, seven cytochalasan alkaloids including six new ones (1-6) and one known derivative (7), one new tyrosine-derived alkaloid (8) , and one known 2-pyrrolidinone alkaloid (9) were isolated from Westerdykella dispersa. To the best of our knowledge, so far only several polyenes including gelastatins A-B and dykellic acid have been reported from the genus Westerdykella 31, 32 . Therefore, this is the first report of these types of alkaloids in this genus.
Materials and Methods
General Experimental Procedures. Optical rotations were measured on an Autopol I automatic polarimeter (Rudolph). UV spectra were recorded on an Agilent spectrophotometer (Agilent Cary60). IR spectra were run on a Bruker spectrophotometer (TENSOR 27). HRESIMS spectra were performed on a Bruker instrument (FTICRMS, SolariX). Nuclear magnetic resonance (NMR) spectra were recorded on an Agilent DD2 spectrometer (400 MHz and 600 MHz). Crystal data was collected on a SuperNova area detector diffractometer (Agilent Technologies Inc.) Melting point (m.p.) was obtained on SGW X-4A. Silica gel (200-300 mesh, Anhui liangchen Inc, China), and Sephadex LH-20 (Pharmacia Biotech, Uppsala, Sweden) were used for column chromatography (CC). Semi-preparative HPLC separation was carried out on Hanbon newstyle instrument (Hanbon Sci. and tech., Jiangsu, China) equipped with two NP7000 serials pumps (flow rate: 2 mL/min) and an NU3000 serials UV detector using a Hedera C18 column (250mm × 10 mm, 5μm, Hanbon Sci. and tech., Jiangsu, China).
Fungal Material and Identification. The fungal strain XL602 was isolated from marine sediments, which were collected at South China Sea, Guangzhou, Guangdong province, China, in July 2014. The species was identified to be Westerdykella dispersa based on sequence analysis of the ITS region of 18 S rDNA (GenBank Accession No. KY604839), and was deposited at the School of Pharmaceutical Sciences, Chongqing University (Huxi Campus). shaker
inoculated with 5.0 mL of the spore inoculum and incubated at room temperature for 30 days.
The fungal cultures of Westerdykella dispersa were ultrasonically extracted four times with MeOH (each time 4 L). The solvent was removed to give a crude extract (10.8 g). The organic extracts were combined and concentrated under reduced pressure to yield 10.8 g of brown oil. This extract was chromatographed on column chromatography (CC) over SiO 2 using a stepwise gradient of petroleum ether/acetone gradient system (9:1, 8:2, 8:4, and 5:5) to yield nine fractions, Fr. 1-9. Fr. 4 (0.5 g) was purified by CC over Sephadex LH-20 (CH 2 Cl 2 /MeOH, 1:1), silica gel CC (petroleum ether/acetone, 5:1), and RP-18 (MeOH/H 2 O, 20:80) to afford compound 9 (4.5 mg). Fr. 6 (0.83 g) was subjected to CC over silica gel (petroleum ether/acetone 6:1, 144:1, 1:1) to yield seven subfractions (6a-6 g). Subfraction 6c was separated by repeated CC over Sephadex LH-20 (CH 2 Cl 2 /MeOH, 1:1) and further purified by semi-preparative HPLC using a C18 column ( Cytotoxicity Assay. Cytotoxicity activity was evaluated against MCF-7, HepG2, A549, HT-29 and SGC-7901 by the MTT method 29 . All cell lines was grown in RPMI-1640 medium (GIBCO) supplemented with 10% heat-inactivated bovine serum, 2 nM glutamine, 10 5 IU/L penicillin, 100 mg/L streptomycin and 10 mM HEPES, pH 7.4. Cells were kept at 37 °C in a humidified 5% CO 2 incubator. An aliquot (180 μL) of these cell suspensions at a density of 1500 cells mL −1 was pipetted into 96-well microtiter plates. Subsequently, 180 μL of sample (in DMSO) at different concentrations was added to each well and incubated for 72 h at the above conditions in a CO 2 incubator. MTT solution (20 µL of 5 mg/L in RPMI-1640 medium) was added to each well and further incubated for 4 h at 37 °C. After addition of 100 µL DMSO and incubation for 1 h, the cells were lysed to liberate the formed formazan crystals. The optical density (OD) was read on a Multiscan plate reader at a wavelength of 492 nm. DMSO control well, in which sample was absent, was included in the experiment in order to eliminate the influence of DMSO. The inhibitory rate of cell proliferation was calculated by the following formula: 10 g/L, pH = 7.4) overnight at 37 °C, and the diluted bacterial suspension (10 6 CFU per milliliter) was ready for detection. The minimum inhibitory concentrations (MIC) of samples and positive control were determined in sterile 96-well plates by the modified broth dilution test 30 . All of wells were filled with 180 μL of bacterial suspension containing 10 6 CFU per milliliter. Test samples (20 μL) with their different concentrations were added into each well. Medium containing DMSO was used as a negative control, ciprofloxacin was used as the positive control. The final concentrations of ciprofloxacin and test compounds were 100, 50, 25, 12.5, 6.25, 3.125, 1.5625, 0.78125 μg/mL in medium. After incubation, the minimum inhibitory concentration (MIC) was defined as the lowest test concentration that completely inhibited the growth of the test organisms. 
